Ambenonium

Active ingredient description

Ambenonium (as ambenonium dichloride) is a cholinesterase inhibitor used in the management of myasthenia gravis. Ambenonium exerts its actions against myasthenia gravis by competitive reversible inhibition of acetylcholinesterase, the enzyme responsible for the hydrolysis of acetylcholine.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Ambenonium
N Nervous system → N07 Other nervous system drugs → N07A Parasympathomimetics → N07AA Anticholinesterases
Discover more medicines within N07AA30

Medicines

$substanceName is the active ingredient of these drugs:

Drug
Countries

France Poland

Structural formula

Graphic representation of the active ingredient's molecular structure

Molecular mass: 537.565 g/mol

External identifiers

CAS Substance: 115-79-7
CAS Substance: 7648-98-8
DrugBank Drug: DB01122
RxNorm Ingredient: 623
SNOMED-CT Concept: 387197009
Ambenonium (substance)
UNII Identifier: L16PUN799N
AMBENONIUM